Home Pendulum Therapeutics

Pendulum Therapeutics

In operation
Series C
Biotechnology R&D Developer
Basic
Enterprise Profile

Basic Information

Pendulum Therapeutics, a biotechnology company dedicated to improving health through microbiome-targeted products, aims to enhance the lives of patients suffering from various diseases. Our formulations of targeted natural bacterial strains help rebalance the microbiome, restoring and improving one’s health. In January 2020, the company launched its first product, a medical probiotic named Pendulum Glucose Control. It is clinically proven to be the only probiotic that reduces blood sugar spikes and A1C levels in individuals with type 2 diabetes, even when used alongside metformin.
Pendulum Therapeutics, Inc.
SanFrancisco,California,United States of America
51~100 people
January 01, 2013
306984@email4pr.com

Enterprise Profile

Industrial Sector
Health Supplement Manufacturing
Technology
Microbial/Viral Technology
Concept
Digestive System Diseases Therapeutic Products # Diabetes Mellitus